sodium acetate
Approved
Sep 24, 1971
Sodium acetate, CH3COONa, also abbreviated NaOAc, is the sodium salt of acetic acid. This salt is colorless, deliquescent, and hygroscopic. — Wikipedia
Clinical trial activity
32 trials · 40 clinical orgs · 13 marketing orgs
Earliest trial started Jan 1, 2008 (NCT00801359)
Timeline
1970s
- Sep 24, 1971
B. Braun — Earliest FDA Approval
- Sep 24, 1971
Evidence of US Marketing
- Sep 24, 1971
B. Braun — Marketing Organization
- Sep 24, 1971
B. Braun — NDA Secondary Org
- Sep 24, 1971
B. Braun — NDA Organization
- Aug 13, 1975
ICU Medical Inc — Marketing Organization
- Aug 13, 1975
ICU Medical Inc — NDA Secondary Org
- Mar 24, 1976
Baxalta — Marketing Organization
- Mar 24, 1976
Baxter — NDA Secondary Org
- Jan 3, 1978
Hospira — Marketing Organization
1980s
- May 4, 1983
Hospira — NDA Secondary Org
2000s
- Sep 27, 2006
Akorn, Inc. — Marketing Organization
- Sep 27, 2006
Epic Pharma Llc — Marketing Organization
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
2010s
2020s
- May 4, 2021
Milla Pharms — Marketing Organization
- Jan 1, 2022
Earliest Phase 3 Sponsor(trial)
- Mar 15, 2024
Hikma — Marketing Organization
Indications
Approved for
Studied for
- Acidosis · Phase 3
- Acute Kidney Injury · Phase 1
- Blood Loss, Surgical · Phase 4
- Brain Neoplasms · Phase 2
- Cataract · Phase 2
- Colorectal Surgery · Phase 4
- Conjunctivitis, Bacterial · Phase 4
- Diabetic Retinopathy · Phase 2
- Epiretinal Membrane · Phase 4
- Glaucoma · Phase 2/Phase 3
- Glaucoma, Neovascular · Phase 2
- Glaucoma, Open-Angle · Phase 2
- Glioma · Phase 2/Phase 3
- Heart Septal Defects, Atrial · Phase 3
- Heart Septal Defects, Ventricular · Phase 3
- Hydroxyethyl Starch Derivatives · Phase 4
- Hypertrophy, Left Ventricular · Phase 3
- Hypovolemia · Phase 4
- Infant, Newborn, Diseases · Phase 3
- Inflammation · Phase 4
- Insulin Resistance · Phase 1
- Non-alcoholic Fatty Liver Disease · Phase 1
- Obesity · Phase 1
- Obstetric Labor Complications · Phase 3
- Ornithine Carbamoyltransferase Deficiency Disease · Phase 3
- Pancreatic Neoplasms · Phase 4
- Perioperative Medicine · Phase 4
- Pharmacology · Phase 2
- Plasma · Phase 4
- Prediabetic State · Phase 1
- Prostatic Neoplasms · Phase 2
- Subarachnoid Hemorrhage · Phase 1
- Tissue Adhesions · Phase 2
Mechanism of action
- ElectrolyteSupplementation
Electrolyte supplementation
Combination products
acetated ringer's
clinimix e 4.25/25 sulfite free w/ elect in dextrose w/ calcium
with amino acids, sodium chloride, calcium chloride, potassium phosphate, glucose monohydrate, magnesium
Also known as clinimix e 2.75/10 sulfite free w/ elect in dextrose w/ calcium, clinimix e 2.75/25 sulfite free w/ elect in dextrose w/ calcium, clinimix e 2.75/5 sulfite free w/ elect in dextrose w/ calcium, clinimix e 4.25/10 sulfite free w/ elect in dextrose w/ calcium, clinimix e 4.25/20 sulfite free w/ elect in dextrose w/ calcium, clinimix e 4.25/5 sulfite free w/ elect in dextrose w/ calcium, clinimix e 5/10 sulfite free w/ elect in dextrose w/ calcium, clinimix e 5/15 sulfite free w/ elect in dextrose w/ calcium, clinimix e 5/20 sulfite free w/ elect in dextrose w/ calcium, clinimix e 5/25 sulfite free w/ elect in dextrose w/ calcium, clinimix e 5/35 sulfite free w/ elect in dextrose w/ calcium
dextrose in acetated ringer's
with potassium chloride, sodium chloride, calcium chloride, glucose monohydrate
dialyte w/ dextrose
with sodium chloride, calcium chloride, glucose monohydrate, magnesium
Also known as dialyte concentrate w/ dextrose
freamine iii w/ electrolytes
with potassium chloride, phosphoric acid, amino acids, sodium chloride, magnesium
isolyte e
with sodium citrate, potassium chloride, sodium chloride, calcium chloride, magnesium
Also known as balanced salt, bss
isolyte e w/ dextrose
with sodium citrate, potassium chloride, sodium chloride, calcium chloride, glucose monohydrate, magnesium
Also known as isolyte e in dextrose
isolyte h w/ dextrose
with potassium chloride, sodium chloride, glucose monohydrate, magnesium
Also known as isolyte h in dextrose
isolyte m w/ dextrose
with potassium chloride, sodium chloride, potassium phosphate, glucose monohydrate
Also known as isolyte m in dextrose
isolyte p w/ dextrose
with potassium chloride, potassium phosphate, glucose monohydrate, magnesium
Also known as isolyte p in dextrose
isolyte r w/ dextrose
with potassium chloride, sodium chloride, calcium chloride, glucose monohydrate, magnesium
Also known as isolyte r in dextrose
isolyte s ph
with potassium chloride, sodium phosphate, sodium chloride, potassium phosphate, sodium gluconate, magnesium
kabiven
with soybean oil, potassium chloride, magnesium sulfate, amino acids, sodium glycerophosphate pentahydrate, calcium chloride, glucose monohydrate
Also known as perikabiven
normosol-r
with potassium chloride, sodium chloride, sodium gluconate, magnesium
Also known as isolyte s, physiolyte, physiosol, physiosol ph, plasma-lyte a
normosol-r and dextrose
with potassium chloride, sodium chloride, glucose monohydrate, sodium gluconate, magnesium
Also known as isolyte s in dextrose, isolyte s w/ dextrose, plasma-lyte 148 and dextrose
plasma-lyte m and dextrose
with potassium chloride, lactic acid, sodium chloride, calcium chloride, glucose monohydrate, magnesium
plasma-lyte r
with potassium chloride, lactic acid, sodium chloride, calcium chloride, magnesium
procalamine
with glycerin, calcium, potassium chloride, phosphoric acid, amino acids, sodium chloride, magnesium
tpn electrolytes
with potassium chloride, sodium chloride, calcium chloride, magnesium
travasol sulfite free w/ electrolytes in dextrose
with amino acids, sodium chloride, potassium phosphate, glucose monohydrate, magnesium
travasol w/ electrolytes
with amino acids, sodium chloride, potassium phosphate, magnesium
Also known as travasol sulfite free w/ electrolytes
veinamine
with potassium chloride, amino acids, potassium acetate, magnesium
Approval history
- approvedPriority reviewSep 24, 1971
- approvedPriority reviewSep 24, 1971
Chemistry & pharmacology
SMILES
[Na+].CC([O-])=O- Mol. weight
- 82.0338 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
Oral
No
Parenteral
Yes
Topical
No
Sources
- WikipediaSodium acetate ↗
- NCATSNVG71ZZ7P0 ↗
- ChEMBLCHEMBL1354 ↗
Also known as
- 13c-sodium acetate
- acetic acid, sodium salt
- acetic acid, sodium salt
- acetic acid, sodium salt
- acetic acid, sodium salt (1:1)
- acetic acid, sodium salt (1:1)
- anhydrous sodium acetate
- anhydrous sodium acetate
- anhydrous sodium acetate
- e262
- e262
- natriumazetat
- natriumazetat
- short chain fatty acids
- short chain fatty acids
- sodium acetate
- sodium acetate
- sodium acetate
- sodium acetate
- sodium acetate
- sodium acetate
- sodium acetate
- sodium acetate
- sodium acetate anhydrous
- sodium acetate anhydrous
- sodium acetate anhydrous
- sodium acetate anhydrous
- sodium acetate,anhydrous
- sodium acetate,anhydrous
- sodium acetate, anhydrous
- sodium acetate, anhydrous
- sodium acetate, anhydrous
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06663254 | Phase 4 | Nov 30, 2024 | Central South University |
| NCT06545565 | Phase 3 | Jul 10, 2024 | Aga Khan University |
| NCT06354088 | Phase 1 | Apr 24, 2024 | Columbia University, University of California, Berkeley |
| NCT05345171 | Phase 3 | Dec 31, 2022 | Ultragenyx Inc. |
| NCT05253209 | Phase 3 | Jun 29, 2022 | Asklepion, Indiana University |
| NCT03338218 | Phase 4 | May 1, 2018 | B. Braun, European Society of Anaesthesiology, Fresenius, Maastricht University |
| NCT03278548 | Phase 4 | Sep 28, 2017 | B. Braun, European Society of Anaesthesiology, Fresenius, Maastricht University |
| NCT03204955 | Phase 1 | Jun 28, 2017 | Emory University |
| NCT02826395 | N/A | Jul 5, 2016 | University of California, Los Angeles |
| NCT02805257 | Phase 2 | Jun 1, 2016 | Asociación para Evitar la Ceguera en México, Bascom Palmer Eye Institute, Sun Yat-Sen University, University of California, San Francisco, University of Colorado, Denver, University of Maryland, University of North Carolina at Chapel Hill |
| NCT02715466 | Phase 4 | Apr 1, 2016 | B. Braun |
| NCT02707549 | Phase 2 | Aug 1, 2015 | University of Sao Paulo |
| NCT02435862 | Phase 2 | Apr 1, 2015 | Allegro Ophthalmics, LLC, Duke University, Trial Runners, LLC |
| NCT02623777 | N/A | Mar 1, 2015 | Katholieke Universiteit Leuven |
| NCT02563847 | N/A | May 1, 2014 | University of Bern |
| NCT01961934 | Phase 2/Phase 3 (Phase 3) | May 1, 2014 | Phoenix Molecular Imaging |
| NCT02051946 | Phase 1/Phase 2 (Phase 2) | May 1, 2014 | Duke University |
| NCT02153476 | Phase 2 | Feb 1, 2014 | Allegro Ophthalmics, LLC |
| NCT03001466 | Phase 2 | Jan 1, 2014 | Assiut University |
| NCT01851616 | N/A | Jan 1, 2013 | University of Basel, University of Bern |
Organizations
Research & Development (40)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| B. Braun | For profit | 4 | 4 | 1 | 2010 |
| Alcon | For profit | 3 | 2 | 2 | 2008 |
| Fresenius | For profit | 3 | 0 | 1 | 2011 |
| Allegro Ophthalmics, LLC | For profit | 2 | 2 | 1 | 2014 |
| Duke University | Academic/Hospital | 2 | 1 | 1 | 2014 |
| European Society of Anaesthesiology | Academic/Hospital | 2 | 0 | 1 | 2017 |
| Maastricht University | Academic/Hospital | 2 | 0 | 1 | 2017 |
| Phoenix Molecular Imaging | Academic/Hospital | 2 | 2 | 2 | 2011 |
| Thomas Jefferson University | Academic/Hospital | 2 | 2 | 1 | 2009 |
| University of Bern | Academic/Hospital | 2 | 2 | 1 | 2013 |
| University of Sao Paulo | Academic/Hospital | 2 | 2 | 1 | 2008 |
| Aga Khan University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Asklepion | For profit | 1 | 1 | 1 | 2022 |
| Asociación para Evitar la Ceguera en México | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Assiut University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Bascom Palmer Eye Institute | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Bayer | For profit | 1 | 0 | 1 | 2011 |
| Central South University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| CLIHON | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Columbia University | Academic/Hospital | 1 | 1 | 1 | 2024 |
Marketing (18)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Abbott | For profit | NDA2 | — |
| Akorn, Inc. | For profit | MKTG | Sep 27, 2006 |
| Alcon | For profit | MKTG | Dec 10, 1997 |
| B. Braun | For profit | MKTG | Sep 24, 1971 |
| B. Braun | For profit | NDA2 | Sep 24, 1971 |
| B. Braun | For profit | NDA | Sep 24, 1971 |
| Baxalta | For profit | MKTG | Mar 24, 1976 |
| Baxter | For profit | NDA2 | Mar 24, 1976 |
| Epic Pharma Llc | For profit | MKTG | Sep 27, 2006 |
| Fresenius | For profit | MKTG | Aug 25, 2014 |
| Fresenius | For profit | NDA2 | Aug 25, 2014 |
| Hikma | For profit | MKTG | Mar 15, 2024 |
| Hospira | For profit | NDA2 | May 4, 1983 |
| Hospira | For profit | MKTG | Jan 3, 1978 |
| ICU Medical Inc | For profit | MKTG | Aug 13, 1975 |
| ICU Medical Inc | For profit | NDA2 | Aug 13, 1975 |
| Milla Pharms | For profit | MKTG | May 4, 2021 |
| Nestle | For profit | NDA2 | Dec 10, 1997 |